COVID19 - USCOM1A sales, page-68

Hi Libart - welcome.
You asked: Is China its only market and is the share price lacking any momentum due to this ?
UCM sells on an international market. It manufactures in Australia and Europe and sells in Australia/NZ, Asia, China, USA, UK, Europe

The best overall introduction is probably the CEO's latest video released on 1 May 20 as it paints the broadest picture.
https://www.uscom.com.au/news/virtual-health-conference-with-nwr/

As to lack of momentum: the company has for some years been reinvesting any gains to establish itself in centers of medical excellence in a world wide market. It has just recently moved into profit. These results have been precipitated by Covid-19 treatment demand. Those who inhabit this board know the story very well and like to pick up any bargains if prices slip.
The company only does official half yearly reporting. So the information in the Quarterly ASX 4C report released recently is really only known to existing shareholders. The wider market will only learn what has changed when the market analysis software picks up the changes late July or August when the annual report is published.
Does this answer your question?